RESEARCH CLINICAL, SUBCLINICAL AND VALUE OF ADENOSIN DEAMINASE IN TUBERCULOUS PLEURISY AT CAN THO TUBERCULOSIS AND LUNG DISEASE HOSPITAL IN 2023-2025
Main Article Content
Abstract
Background: Tuberculous pleural effusion is the leading cause of exudative effusion in countries with hight tuberculosis prevalence, including Vietnam. Research clinical, subcinical and value of Adenosin Deaminase in patient tuberculous pleural effusion help us clearly understand about this disease and make diagnosis easier. Objectives: To describe clinical, subclinical and value of Adenosin Deaminase in tuberculous pleurisy. Materials and method: A cross-sectional descriptive study was conducted on 42 patients diagnosed with tuberculous pleural efusion at Can Tho Tuberculosis and Lung Disease Hospital. Results: The male rate was 78.6% and female was 21.6%, male/female ratio was 3.6/1. The age of group 40-60 had the highest proportion (<40 years old was 11.9%; 40-60 years old was 45.2%; >60 years old was 42.9%). Symptoms were dry cough (76.2%), coughing up phlegm (14.3%), chest pain (90.5%), dyspnea (71.4%), weight loss (64.3%), fever (50%). Signs were triple hypo syndrome (97.6%), consolidation syndrome (2.4%). A straight chest X-ray with right (50%), left (38.1%), bilaterial (11.9%). Pleural effusion amount was small (2.4%), moderate (73.8%), and large (23.8%). Distribution of free fluid (90.5%), septate (9.5%). Characteristics of pleural fluid, the predominance was yellow (100%). The cell formula in the pleural fluid was 1336.05±1008.12 cells/mm3 and lymphocyte was 100%. Adenosine Deaminase value was 60.06±19.37 UI/L. Conclusions: Tuberculous pleurisy was predominanted in men, 40-60 years old. Common symptoms were chest pain, dry cough, dyspnea, triple hypo syndrome. The common location of pleural effusion was right, moderate level, free fluid distribution. Lymphocyte was dominanted cell formula. Adenosine Deaminase value was 60.06±19.37 UI/L.
Keywords
Tuberculous pleural effusion, tuberculous pleurisy, Adenosin Deaminase
Article Details
References
2. Stéphane Beaudoin, Anne V.Gonzalez. Evaluation of the patient with pleural effusion. CMAJ.
2018.190(10), E291-E5, doi: 10.1503/cmaj.170420.
3. WHO. Global Tuberculosis Report. 2022.
4. Light R.W.. Update on tuberculous pleural effusion. 2010.15(3), 451-458.
5. Ngô Thế Hoàng, Lê Hà Hồng Thạnh, Hoàng Thái Dương. Giá trị của Adenosin Deaminase trong chẩn đoán tràn dịch màng phổi do lao. Tạp chí Y Học TP Hồ Chí Minh. 2016.6, 56-60.
6. Masafumi Shimoda, Aya Hirata, Yoshiaki Tanaka. Characteristics of pleural effusion with a high adenosine deaminase level: a case-control study. BMC Pulm Med. 2022.22(1), 359, doi: 10.1186/s12890-022-02150-4.
7. Trịnh Thị Hương, Ngô Quý Châu (2007), "Đặc điểm lâm sàng- cận lâm sàng và kết quả điều trị 768 bệnh nhân tràn dịch màng phổi", Nghiên cứu Y Học, 5, pp. 72-79.
8. Cao Xuân Thục, Trần Văn Ngọc. Vai trò của Adenosine Deaminase và Interferon Gamma trong chẩn đoán tràn dịch màng phổi do lao. Y Học TP Hồ Chí Minh. 2017.21(2), 164-71.
9. Nguyễn Thị Cẩm Tú. Khảo sát đặc điểm lâm sàng, cận lâm sàng, nguyên nhân, đánh giá kết quả điều trị tràn dịch màng phổi dịch tiết tại bệnh viện Lao và bệnh Phổi Cần Thơ.2016.
10. Eusebi Chiner, Miriam Nomdedeu, Sandra Vañes. Clinical and Epidemiological Features of Tuberculous Pleural Effusion in Alicante, Spain. Journal of Clinical Medicine. 2021.10, 4392, doi: 10.3390/jcm10194392.
11. Trần Hoàng Duy. Đánh giá kết quả sinh thiết màng phổi ở bệnh nhân tràn dịch màng phổi dịch tiết tại Bệnh viện Lao và Bệnh Phổi Cần Thơ năm 2018. Tạp chí Y Dược Cần Thơ. 2019. 22-23-24-25.
12. Qiu-Li Liang, Huan Zhong Shi., Ke Wang, Shou-Ming Qin, Xue-Jun Qin. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A meta-analysis. Respiratory Medicine. 2008.102, 74454, doi: 10.1016/j.rmed.2007.12.007.